These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Shen ZX; Chen GQ; Ni JH; Li XS; Xiong SM; Qiu QY; Zhu J; Tang W; Sun GL; Yang KQ; Chen Y; Zhou L; Fang ZW; Wang YT; Ma J; Zhang P; Zhang TD; Chen SJ; Chen Z; Wang ZY Blood; 1997 May; 89(9):3354-60. PubMed ID: 9129042 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. Leu L; Mohassel L Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute promyelocytic leukemia with arsenic trioxide. Conrad ME N Engl J Med; 1999 Apr; 340(13):1043-5. PubMed ID: 10189286 [No Abstract] [Full Text] [Related]
8. [Arsenic trioxide in the treatment of acute promyelocytic leukaemia]. Ercilla Liceaga M; Andueza Granados K; Fernández González I; Barcia Romero MJ Farm Hosp; 2003; 27(2):93-100. PubMed ID: 12717564 [TBL] [Abstract][Full Text] [Related]
9. The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia. Zhu H; Hu J; Chen L; Zhou W; Li X; Wang L; Zhao X; Zhang Y; Zhao H; Wang A; Chen Y; Sun H; Chen Q; Chen Y; Zhao W; Mi J; Shen Z; Wang Z; Chen Z; Chen S; Li J Blood; 2016 Sep; 128(11):1525-8. PubMed ID: 27402972 [No Abstract] [Full Text] [Related]
10. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Niu C; Yan H; Yu T; Sun HP; Liu JX; Li XS; Wu W; Zhang FQ; Chen Y; Zhou L; Li JM; Zeng XY; Yang RR; Yuan MM; Ren MY; Gu FY; Cao Q; Gu BW; Su XY; Chen GQ; Xiong SM; Zhang TD; Waxman S; Wang ZY; Chen Z; Hu J; Shen ZX; Chen SJ Blood; 1999 Nov; 94(10):3315-24. PubMed ID: 10552940 [TBL] [Abstract][Full Text] [Related]
11. New data with arsenic trioxide in leukemias and myelodysplastic syndromes. Sekeres MA Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 1():S7-S12. PubMed ID: 18282365 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside. Rojewski MT; Körper S; Schrezenmeier H Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751 [TBL] [Abstract][Full Text] [Related]
17. Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies. Liu P; Han ZC Int J Hematol; 2003 Jul; 78(1):32-9. PubMed ID: 12894848 [TBL] [Abstract][Full Text] [Related]
18. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation. Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide. Hirayama Y; Koyama R; Nagai T; Ohta H; Kondo A; Ishikawa K; Ishitani K; Matsunaga T; Sakamaki S; Niitsu Y Intern Med; 2001 Nov; 40(11):1136-9. PubMed ID: 11757771 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of all-trans retinoic acid resistant and chemotherapy naïve acute promyelocytic patients with arsenic trioxide--two case reports. Lin CP; Huang MJ; Chang IY; Lin WY Leuk Lymphoma; 2000 Jun; 38(1-2):191-4. PubMed ID: 10811462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]